Haoxi Health Technology Limited (HAO)
ValueMarkers Composite Index
99% below intrinsic value ($77)
Haoxi Health Technology Limited (HAO) — VMCI valuation read
Haoxi Health Technology Limited (HAO) carries a VMCI composite of 62/100, 12 points above the Communication Services sector median of 50. Among mid-cap names, that gap places HAO in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).
The HAO insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.
**Investor frame.** Value reads HAO trades at 14.0x earnings, 22% below the Communication Services median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Communication Services 12.0x. Quality: ROIC of 18.0% sits 8.0pp above the Communication Services median (10.0%). Risk: net debt to EBITDA of 2.6x is the rate-sensitivity line to watch, the line to track on Haoxi Health Technology Limited's next 10-Q.
HAO fell 0.6% over the trailing 7 days, with a -2.7% read on a 30-day basis.
Related Stocks in Communication Services
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.